HUP0302563A2 - Az N-(1-hidroxi-metil)-2,3-dihidroxi-propil)-1,4,7-trisz-(karboxi-metil)-1,4,7,10-tetraazaciklododekán lítiumkomplexei, ezek előállítása és alkalmazása - Google Patents

Az N-(1-hidroxi-metil)-2,3-dihidroxi-propil)-1,4,7-trisz-(karboxi-metil)-1,4,7,10-tetraazaciklododekán lítiumkomplexei, ezek előállítása és alkalmazása

Info

Publication number
HUP0302563A2
HUP0302563A2 HU0302563A HUP0302563A HUP0302563A2 HU P0302563 A2 HUP0302563 A2 HU P0302563A2 HU 0302563 A HU0302563 A HU 0302563A HU P0302563 A HUP0302563 A HU P0302563A HU P0302563 A2 HUP0302563 A2 HU P0302563A2
Authority
HU
Hungary
Prior art keywords
production
tetraazacyclododecane
lithium
triscarboxymethyl
dihydroxypropyl
Prior art date
Application number
HU0302563A
Other languages
English (en)
Inventor
Peter Blaszkiewicz
Holger Mann
Orlin Petrov
Johannes Platzek
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP0302563A2 publication Critical patent/HUP0302563A2/hu
Publication of HUP0302563A3 publication Critical patent/HUP0302563A3/hu
Publication of HU229657B1 publication Critical patent/HU229657B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02Lithium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

A találmány (I) általános képletű vegyületekre, a képletben a három Xjelentése együttesen n lítiumion és m hidrogénatom, ahol n és m értéke0-3, és n és m összege = 3, Y jelentése klorid vagy bromid, és avegyületek előállítására alkalmas eljárásra vonatkozik, amelyrejellemző, hogy N-(6-hidroxi-2,2-dimetil-1,3-dioxepán-5-il)-1,4,7,10-tetraazaciklododekánt vagy annak lítium-kloriddal vagy lítium-bromiddal alkotott komplexét klór vagy brómecetsavval és lítium-hidroxiddal poláris oldószerben reagáltatják. Az (I) általános képletűvegyületek gadobutrol előállítására alkalmazhatók. Ó
HU0302563A 2000-12-15 2001-12-05 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof HU229657B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064467A DE10064467C2 (de) 2000-12-15 2000-12-15 Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung
PCT/EP2001/014283 WO2002048119A2 (de) 2000-12-15 2001-12-05 Lithium-komplexe von n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren herstellung und verwendung

Publications (3)

Publication Number Publication Date
HUP0302563A2 true HUP0302563A2 (hu) 2003-12-29
HUP0302563A3 HUP0302563A3 (en) 2011-04-28
HU229657B1 HU229657B1 (en) 2014-03-28

Family

ID=7668584

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302563A HU229657B1 (en) 2000-12-15 2001-12-05 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof

Country Status (35)

Country Link
US (1) US6894151B2 (hu)
EP (1) EP1343770B1 (hu)
JP (1) JP4399163B2 (hu)
KR (1) KR100869627B1 (hu)
CN (1) CN1229357C (hu)
AR (1) AR035609A1 (hu)
AT (1) ATE430737T1 (hu)
AU (2) AU2002231659B2 (hu)
BG (1) BG66117B1 (hu)
BR (1) BR0116219A (hu)
CA (1) CA2431976C (hu)
CY (1) CY1109280T1 (hu)
CZ (1) CZ304573B6 (hu)
DE (2) DE10064467C2 (hu)
DK (1) DK1343770T3 (hu)
EC (1) ECSP034676A (hu)
EE (1) EE05245B1 (hu)
ES (1) ES2325982T3 (hu)
HK (1) HK1064098A1 (hu)
HR (1) HRP20030576B1 (hu)
HU (1) HU229657B1 (hu)
IL (1) IL156432A0 (hu)
ME (1) ME00157B (hu)
MX (1) MXPA03005240A (hu)
NO (1) NO324864B1 (hu)
NZ (1) NZ526478A (hu)
PL (1) PL204181B1 (hu)
PT (1) PT1343770E (hu)
RS (1) RS51862B (hu)
RU (1) RU2003120513A (hu)
SK (1) SK287424B6 (hu)
TW (1) TWI302531B (hu)
UY (1) UY27056A1 (hu)
WO (1) WO2002048119A2 (hu)
ZA (1) ZA200305421B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112840A2 (en) * 2003-06-25 2004-12-29 Guerbet Peptide conjugate for magnetic resonance imaging
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
EP1765812B1 (en) * 2004-07-02 2009-04-29 Bracco Imaging S.p.A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
KR20080108989A (ko) * 2006-03-14 2008-12-16 말린크로트, 인코포레이티드 테트라아자거대고리 유도체의 금속 착체
US7777029B2 (en) * 2006-05-02 2010-08-17 San Diego State University (Sdsu) Foundation Bifunctional chelators for sequestering lanthanides
DE102009057274B4 (de) 2009-12-02 2011-09-01 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels Trioxobicyclo-octan
WO2011054480A1 (de) 2009-11-09 2011-05-12 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer membran
DE102009053252B3 (de) * 2009-11-09 2011-09-01 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer Membran
DE102010013833A1 (de) 2010-03-29 2011-09-29 Bayer Schering Pharma Aktiengesellschaft Herstellung von Gadobutrol mittels Dimethylformamiddimethylacetal
DE102010023105A1 (de) 2010-06-04 2011-12-08 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol
RS60001B1 (sr) 2011-04-21 2020-04-30 Bayer Ip Gmbh Pripremanje gadobutrola visoke čistoće
CN106543094A (zh) * 2016-11-04 2017-03-29 嘉实(湖南)医药科技有限公司 高纯度钆布醇的制备方法
KR101971435B1 (ko) * 2017-08-29 2019-04-24 주식회사 엔지켐생명과학 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법
KR102033964B1 (ko) * 2018-01-19 2019-10-18 주식회사 엔지켐생명과학 가도테리돌 중간체 및 이를 이용한 가도테리돌 제조방법
CN111039885B (zh) * 2019-12-06 2021-03-05 广州康瑞泰药业有限公司 一种制备高纯度考布曲钙的方法
KR20210112910A (ko) * 2020-03-06 2021-09-15 주식회사 엔지켐생명과학 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE19724186C2 (de) 1997-06-02 2002-07-18 Schering Ag Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe

Also Published As

Publication number Publication date
RU2003120513A (ru) 2004-12-27
CZ304573B6 (cs) 2014-07-16
CA2431976A1 (en) 2002-06-20
HK1064098A1 (en) 2005-01-21
NZ526478A (en) 2006-04-28
ZA200305421B (en) 2004-08-27
BG66117B1 (bg) 2011-05-31
NO20032523L (no) 2003-06-04
EP1343770B1 (de) 2009-05-06
CZ20031641A3 (cs) 2003-09-17
HU229657B1 (en) 2014-03-28
AU3165902A (en) 2002-06-24
BG107901A (bg) 2004-06-30
NO20032523D0 (no) 2003-06-04
DE50114889D1 (de) 2009-06-18
YU48103A (sh) 2006-05-25
CA2431976C (en) 2010-04-13
CN1481371A (zh) 2004-03-10
EE200300282A (et) 2003-10-15
TWI302531B (en) 2008-11-01
ECSP034676A (es) 2003-08-29
PL204181B1 (pl) 2009-12-31
KR100869627B1 (ko) 2008-11-21
WO2002048119A3 (de) 2002-11-07
DE10064467A1 (de) 2002-07-11
MXPA03005240A (es) 2003-09-25
JP4399163B2 (ja) 2010-01-13
KR20030077555A (ko) 2003-10-01
PL366141A1 (en) 2005-01-24
IL156432A0 (en) 2004-01-04
EE05245B1 (et) 2009-12-15
SK7292003A3 (en) 2003-11-04
DK1343770T3 (da) 2009-08-10
ES2325982T3 (es) 2009-09-28
UY27056A1 (es) 2002-07-31
US20020128472A1 (en) 2002-09-12
AU2002231659B2 (en) 2007-07-05
EP1343770A2 (de) 2003-09-17
WO2002048119A2 (de) 2002-06-20
MEP15708A (en) 2010-06-10
CN1229357C (zh) 2005-11-30
HRP20030576A2 (en) 2005-06-30
SK287424B6 (sk) 2010-09-07
HUP0302563A3 (en) 2011-04-28
RS51862B (sr) 2012-02-29
JP2004515545A (ja) 2004-05-27
US6894151B2 (en) 2005-05-17
ME00157B (me) 2010-10-10
NO324864B1 (no) 2007-12-17
PT1343770E (pt) 2009-07-20
CY1109280T1 (el) 2014-07-02
ATE430737T1 (de) 2009-05-15
AR035609A1 (es) 2004-06-16
HRP20030576B1 (en) 2011-09-30
BR0116219A (pt) 2006-02-21
DE10064467C2 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
HUP0302563A2 (hu) Az N-(1-hidroxi-metil)-2,3-dihidroxi-propil)-1,4,7-trisz-(karboxi-metil)-1,4,7,10-tetraazaciklododekán lítiumkomplexei, ezek előállítása és alkalmazása
HUP0202251A2 (hu) Heterociklust tartalmazó bifenil aP2 inhibitorok és alkalmazásuk
ATE246178T1 (de) Herstellung von mono- und 1,7-bis-n-hydroxyalkyl- cyclen und lithium-salz-komplexen
HUP0302943A2 (hu) Új heterociklusos vegyületek, előállításuk és alkalmazásuk gyógyszerekként, különösen antibakteriális szerekként
TNSN99095A1 (fr) 4 - phenylpiperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DE60215814D1 (de) Vinylphenyl-derivate als glk-aktivatoren
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
CY1109740T1 (el) Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ
EA200500862A1 (ru) Синоменин и соединения синоменина, синтез и применение
HUP0102477A2 (hu) VLA-4 függő sejtadhézió nempeptid inhibitorainak felhasználása gyulladásos, autoimmun és légzési betegségek kezelésére és a vegyületeket tartalmazó gyógyszerkészítmények
DE602005024824D1 (de) Verfahren zur herstellung von substituierten tetrazolen aus aminotetrazolen
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
HUP0204011A2 (en) 1,2-diaryl benzimidazoles, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions for treating illnesses associated with a microglia activation
NO20055750L (no) Nye kjemiske forbindelser
HUP9901339A2 (hu) Eljárás N-szubsztituált-3-hidroxi-pirazol-származékok előállítására
FR2839155B1 (fr) Procede pour detecter et localiser des traces de sang et compose pour detecter des traces de sang
ATE375350T1 (de) Modulatoren von peroxisome proliferator- aktivierten rezeptoren
BR0312183A (pt) Uso de compostos benzisosselenazolonas contra lesão miocárdica isquêmica
YU36104A (sh) Kristalna struktura fosfodiesteraza 5 i njihova upotreba
SE0201016L (sv) Sätt att behandla restsyra
HUP0500082A2 (hu) Endotelin-antagonista aktivitású alkán-szulfonamidok és alkalmazásuk
TH55357B (th) สารเชิงซ้อนลิเทียมของ n-(1-ไฮดรอกซี่เมทิล-2,3-ไดไฮดรอกซีโพรพิล)-1,4,7-ทริสคาร์บอกซี่เมทิล-1,4-7-10-เตตระอะชาไซโคลโดเดเคน, การผลิต และการใช้ของพวกมัน
DE50111217D1 (de) 1h-pyrazol-derivate, verfahren zu ihrer herstellung, und ihre verwendung als nitrifikationsinhibitoren
HUP0301672A2 (hu) Eljárás peszticid hatású vegyületek előállítására
JO2187B1 (en) Production and use of complex lithium compounds for N- (1- hydroxy methyl -2-3-dihydroxypropyl) -1,4,7- tri-carboxy methyl -1,4,7,10- tetra-azaclododecane

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Free format text: FORMER OWNER(S): SCHERING AG., DE

TH4A Erratum